VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

51 hedge funds and large institutions have $30.3M invested in VistaGen Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+2
Holders Change %
+4.08%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
18
Reduced
11
Closed
4
Calls
$437K
Puts
$73K
Net Calls
+$364K
Net Calls Change
+$339K

Top Buyers

1
Jane Street
Jane Street
New York
$190K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$231K
3
AI
AdvisorShares Investments
Maryland
$406K
4
SC
Stempoint Capital
New York
$4.12M
5
Marshall Wace
Marshall Wace
United Kingdom
$69.3K

Top Sellers

1
SFM
Sphera Funds Management
Israel
$896K
2
Vanguard Group
Vanguard Group
Pennsylvania
$3.52M
3
DP
Diadema Partners
New Jersey
$808K
4
Morgan Stanley
Morgan Stanley
New York
$24.3K
5
PAP
Persistent Asset Partners
Hong Kong
$174K
Name Holding Trade Value Shares
Change 		Shares
Change %
PWM
51
Prosperity Wealth Management
California
– -$69K -27,600 Closed
CSS
52
Cubist Systematic Strategies
Connecticut
– -$25.2K -10,088 Closed
BT
53
Banque Transatlantique
France
– -$2.31K -1,000 Closed
SIC
54
SJS Investment Consulting
Ohio
– -$250 -100 Closed
1 2
3